Sagent Pharmaceuticals, Inc. Sustainability Profile
Sagent Pharmaceuticals, Inc., a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a leader in the development and manufacturing of injectable pharmaceuticals, focusing on high-quality, cost-effective solutions for healthcare providers. With a strong operational presence across North America, Sagent Pharmaceuticals offers a diverse portfolio of products, including generic and specialty injectables that cater to various therapeutic areas. Their commitment to quality and innovation has earned them a solid market position, recognised for their unique approach to sterile injectable manufacturing. Notable achievements include a robust pipeline of products and strategic partnerships that enhance their capabilities in delivering essential medications. Sagent Pharmaceuticals continues to prioritise patient safety and efficacy, making significant strides in the ever-evolving pharmaceutical landscape.
DitchCarbon Score
How does Sagent Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sagent Pharmaceuticals, Inc.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Sagent Pharmaceuticals, Inc.'s reported carbon emissions
Sagent Pharmaceuticals, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organisation. In terms of climate commitments, Sagent Pharmaceuticals has not outlined any specific reduction targets or initiatives, nor have they made any public climate pledges. This lack of data and commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the pharmaceutical industry increasingly focuses on sustainability, Sagent Pharmaceuticals may benefit from establishing clear emissions reduction goals and participating in recognised initiatives to enhance its environmental performance and transparency.
How Carbon Intensive is Sagent Pharmaceuticals, Inc.'s Industry?
How Carbon Intensive is Sagent Pharmaceuticals, Inc.'s Location?
Sagent Pharmaceuticals, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Sagent Pharmaceuticals, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
